FDA’s priority review gives opioid-overdose reversal drug expected approval date of March 2023, company says

This post first appeared on wsj.com

You May Also Like

Sullivan says Biden admin. never took ‘its eye off the ball’ with Israel’s security challenges

IE 11 is not supported. For an optimal experience visit our site…

‘SNL’ spotlights Trump’s Senate acquittal

“Saturday Night Live” had fun with the measured approval expressed by some…

The Best Cities for Remote Work

6th for workplace, 6th for affordability 2nd for affordability, 3rd for workplace…

Texas appeals court blocks state from probing transgender kids’ parents

A Texas appeals court on Friday upheld a lower court’s injunction blocking…